Similar articles

• Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin.

  Tomio L, Calzavara F, Zorat PL, Corti L, Polico C, Reddi E, Jori G, Mandoliti G. Tomio L, et al. Prog Clin Biol Res. 1984;170:829-40. Prog Clin Biol Res. 1984. PMID: 6531372 No abstract available.
• Effectiveness of HPD and radiation therapy in lung cancer.

  Kato H, Konaka C, Ono J, Matsushima Y, Nishimiya K, Lay J, Sawa H, Shinohara H, Saito T, Kinoshita K, Tomono T, Aida M, Hayata Y. Kato H, et al. Adv Exp Med Biol. 1983;160:23-39. doi: 10.1007/978-1-4684-4406-3_4. Adv Exp Med Biol. 1983. PMID: 6301227 No abstract available.
• Photoradiation of malignant tumors presensitized with hematoporphyrin derivative.

  McCaughan JS Jr. McCaughan JS Jr. Prog Clin Biol Res. 1984;170:805-27. Prog Clin Biol Res. 1984. PMID: 6241717 No abstract available.
• [New methods of locating and treating malignant neoplasms by using a hematoporphyrin derivative and photoradiation].

  Zawirska B. Zawirska B. Postepy Hig Med Dosw. 1987 Nov-Dec;41(6):579-96. Postepy Hig Med Dosw. 1987. PMID: 2967470 Review. Polish. No abstract available.
• [Mechanism of action and clinical use of photoactivated hematoporphyrins in oncology].

  Stanowski E, Graczyk A, Konarski J, Sobczyńska J. Stanowski E, et al. Pol Tyg Lek. 1986 Jun 9;41(23):758-65. Pol Tyg Lek. 1986. PMID: 2945169 Review. Polish. No abstract available.